
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.72 | 1.72 | 0.00 |
Shares | 98.28 | 98.28 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.40 | 24.02 |
Price to Book | 4.99 | 4.63 |
Price to Sales | 3.82 | 3.58 |
Price to Cash Flow | 12.96 | 15.71 |
Dividend Yield | 1.46 | 1.29 |
5 Years Earnings Growth | 11.41 | 10.70 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 25.90 | 15.03 |
Technology | 21.34 | 28.37 |
Healthcare | 16.23 | 13.77 |
Communication Services | 13.72 | 9.15 |
Consumer Defensive | 10.19 | 6.05 |
Consumer Cyclical | 6.87 | 12.30 |
Industrials | 5.75 | 12.52 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Visa A | US92826C8394 | 6.99 | 345.47 | -1.55% | |
Alphabet A | US02079K3059 | 6.95 | 191.90 | -2.36% | |
Fiserv | US3377381088 | 6.14 | 138.94 | -1.36% | |
Mastercard | US57636Q1040 | 5.58 | 566.47 | +1.32% | |
Roche Holding Participation | CH0012032048 | 5.13 | 257.10 | -0.96% | |
Microsoft | US5949181045 | 5.00 | 533.50 | +3.95% | |
Meta Platforms | US30303M1027 | 4.72 | 773.44 | +11.25% | |
London Stock Exchange | GB00B0SWJX34 | 4.25 | 9,260.0 | -7.91% | |
Heineken | NL0000008977 | 4.17 | 59.40 | -2.94% | |
Amadeus | ES0109067019 | 4.14 | 70.420 | -0.42% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Troy Trojan O Acc | 869M | 2.40 | 3.97 | 5.41 | ||
Troy Trojan O Inc | 204.26M | 2.54 | 4.05 | 5.43 | ||
Troy Trojan S Acc | 131.29M | 2.50 | 4.21 | 5.67 | ||
Troy Trojan S Inc | 141.44M | 2.54 | 4.24 | 5.68 | ||
GB00BZ6CNS31 | 2.03B | 6.67 | 1.87 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review